63.72 F
New York, US
May 16, 2024
PreetNama
English News

France asks Israel to drop West Bank annexation plans

Emmanuel Macron asked Israel’s Prime Minister Benjamin Netanyahu to refrain from annexing Palestinian territory in the West Bank and elsewhere during a telephone call between the two leaders, the French president’s office said on Friday.

Macron “emphasised that such a move would contravene international law and jeopardise the possibility of a two-state solution as the basis of a fair and lasting peace between Israelis and Palestinians”, his office said in a statement after the call on Thursday.

It was the latest move by European leaders pressing Netanyahu to drop plans to annex Jewish settlements in the West Bank and the strategic Jordan Valley.

The controversial move was endorsed in a Middle East plan unveiled by US President Donald Trump in January.

Israel’s government had set July 1 as the date when it could begin taking over the Palestinian areas, where the population of Israeli settlers has grown since the 1967 Six-Day War.

The foreign ministries of France and Germany, along with those of Egypt and Jordan — the only Arab states to have peace deals with Israel — warned this week that any annexation could have “consequences” for relations.

But Macron told Netanyahu that France remained committed to Israel’s security and “expressed his attachment to the friendship and confidence that links France and Israel”, his office said.

Related posts

Rising cases in US, Europe fuel another global surge

On Punjab

Myanmar court postpones verdicts in second case against Suu Kyi

On Punjab

he plans for AstraZeneca’s new headquarters and large R&D campus in Cambridge were unveiled in 2013, but its costs and timeframe have exceeded the initial estimate of 330 million pounds and an aimed completion date of 2016. AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialised medicines and next-generation therapeutics, including gene-editing and cell therapies. “We will have advances that could come to the clinic in the next three, four years, that can lead to really effective new drugs in various aspects of treating cancer,” Dr Susan Galbraith, AstraZeneca’s executive vice president, Oncology Research & Development, told Reuters in an interview. “I’m very optimistic about the fact that we can make a big difference to this disease in the coming decade”.

On Punjab